ETrade Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $981K | Sell |
4,330
-308
| -7% | -$69.8K | 0.02% | 380 |
|
|
2020
Q2 | $809K | Sell |
4,638
-215
| -4% | -$37.5K | 0.02% | 418 |
|
|
2020
Q1 | $612K | Sell |
4,853
-534
| -10% | -$67.3K | 0.02% | 416 |
|
|
2019
Q4 | $823K | Sell |
5,387
-206
| -4% | -$31.5K | 0.02% | 409 |
|
|
2019
Q3 | $740K | Buy |
5,593
+426
| +8% | +$56.4K | 0.02% | 431 |
|
|
2019
Q2 | $733K | Sell |
5,167
-20
| -0.4% | -$2.84K | 0.02% | 430 |
|
|
2019
Q1 | $754K | Sell |
5,187
-383
| -7% | -$55.7K | 0.02% | 407 |
|
|
2018
Q4 | $630K | Buy |
5,570
+8
| +0.1% | +$905 | 0.02% | 426 |
|
|
2018
Q3 | $748K | Buy |
5,562
+393
| +8% | +$52.9K | 0.02% | 455 |
|
|
2018
Q2 | $580K | Buy |
5,169
+422
| +9% | +$47.4K | 0.02% | 495 |
|
|
2018
Q1 | $507K | Buy |
4,747
+2,758
| +139% | +$295K | 0.02% | 508 |
|
|
2017
Q4 | $218K | Buy |
+1,989
| New | +$218K | 0.01% | 695 |
|